Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
42%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
19%
ALSO IN MEDX
MEDX
27
HOLDINGS
41%
ALSO IN XLV
SECTOR DRIFT (XLV minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.2% | 17.1% | 15.2% |
|
ABBVIE INC | 7.1% | 8.2% | 7.1% |
|
JOHNSON & JOHNSON | 10.4% | 5.5% | 5.5% |
|
MERCK & CO. INC. | 5.3% | 3.8% | 3.8% |
|
AMGEN INC | 3.3% | 3.9% | 3.3% |
XLV Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 6.8% |
|
JOHNSON & JOHNSON | 4.9% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% |
|
GILEAD SCIENCES INC | 3.1% |
|
INTUITIVE SURGICAL INC | 2.8% |
|
ABBOTT LABORATORIES | 2.8% |
|
CVS CAREMARK CORP | 2.3% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
|
STRYKER CORP | 2.0% |
|
DANAHER CORP | 1.9% |
XLV Underweight Relative to MEDX
 |
NOVARTIS AG-ADR | -7.2% |
 |
ASTRAZENECA PLC | -5.4% |
|
IONIS PHARMACEUTICALS, INC. | -4.7% |
 |
ALKERMES PLC | -4.4% |
|
ALNYLAM PHARMACEUTICALS INC | -3.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.8% |
|
BRISTOL-MYERS SQUIBB CO | -2.6% |
|
CRISPR THERAPEUTICS AG | -2.6% |
|
BIOGEN IDEC INC | -2.5% |
|
ELI LILLY & CO | -2.0% |